AGIC Capital Completes Growth Equity Investment into AP Technologies

Significant Investment Positions AP Technologies for Continued Success in Medical Device Manufacturing

In a major move that will propel the growth of AP Technologies, AGIC Capital, a leading European-Asian private equity firm, has completed a growth equity investment into the emerging medical device contract manufacturer. AP Technologies specializes in providing highly-engineered solutions for critical healthcare applications, with a focus on medical tubing and catheter manufacturing using advanced extrusion and assembly processes.

This strategic investment comes at a crucial time as the demand for complex medical extrusions and interventional catheters continues to rise. AP Technologies is well-positioned to capitalize on the increasing need for diagnostic and therapeutic solutions in the healthcare industry, both in Asia and globally. The company has already established itself as a premier contract manufacturer, serving blue-chip customers in diagnostics, interventional cardiology, neurology, and diabetic care.

AGIC Capital's investment marks a significant milestone for AP Technologies and demonstrates AGIC's commitment to expanding its geographic focus along the Europe-Asia axis. This transaction also represents AGIC's inaugural investment in Asia with its Fund II. By partnering with AP Technologies, AGIC aims to support the company's core business while enhancing its technological capabilities. The investment will enable AP Technologies to accelerate its global development strategy and make key investments in research and development.

Charles Tang, CEO and Co-Founder of AP Technologies, expressed his excitement about the partnership with AGIC, stating, "We are thrilled to be partnering with AGIC as a leading life science investor. Their support will not only help us grow our core business but also enable us to enhance our technological capabilities. We look forward to a successful journey with the AGIC team."

Ken He, Director at AGIC, commented on the investment, saying, "We are very impressed with AP's strong technical capabilities and focus on product quality. The company's exceptional track record in working with world-class customers is a testament to its dedication to fulfilling unique demands in the medical device industry. We are excited to contribute our capital and life science expertise to AP's growth and expansion."

The investment from AGIC Capital highlights AP Technologies' position as an industry leader and reaffirms its commitment to maintaining the highest quality standards. The company utilizes a comprehensive quality control system, advanced statistical methodologies, and a state-of-the-art facility to ensure the utmost precision and reliability in its medical tubing and catheter manufacturing processes.

USIC Capital's investment in AP Technologies is indicative of the company's dedication to supporting thriving middle-market businesses focused on advanced industrial and healthcare technologies. With $2.2 billion in assets under management, AGIC combines deep business model expertise with proactive thematic research to create long-term value. The firm's collaborative, management-first approach sets it apart in the private equity landscape.

About AP Technologies

AP Technologies is a Singapore-based medical device contract manufacturer specializing in precision medical tubing and catheters. With cutting-edge extrusion and assembly processes, the company delivers tight tolerance solutions for critical healthcare applications. AP Technologies maintains the highest quality standards in the industry through its comprehensive quality control system and state-of-the-art facility. For more information, visit www.ap-tech.com.

About AGIC Capital

AGIC Capital is a growth-oriented private equity firm that invests in middle-market businesses focused on advanced industrial and healthcare technologies. With a Europe-Asia focus, AGIC leverages its expertise and proactive research to drive value creation. The firm currently manages $2.2 billion in assets and has a team of more than 25 professionals based in Europe and Asia. For more information about AGIC's investment philosophy, visit www.agic-group.com.

In conclusion, the investment from AGIC Capital represents a significant opportunity for AP Technologies to expand its operations, enhance its technological capabilities, and continue delivering high-quality medical devices to the healthcare industry. The partnership between these two industry leaders sets the stage for a successful and mutually beneficial journey towards growth and innovation in the medical device manufacturing sector.